Curcumin: A Potent Modulator of Multiple Enzymes in Multiple Cancers.

作者: Adeeb Shehzad , Raheem Shahzad , Young Sup Lee

DOI: 10.1016/B978-0-12-802215-3.00008-2

关键词: Cell signalingProteasomeGene mutationDNMT1CurcuminBiologyProtein kinase CEnzymeKinaseBiochemistry

摘要: Curcumin (diferuloylmethane) is the biphenolic active compound of turmeric. has been used for hundreds years to treat various ailments. reported exert numerous pharmacological effects by modulating multiple molecular targets including those involved in pathogenesis cancer. Cancer characterized as dysregulation cell signaling pathways through gradual alteration regulatory proteins and gene mutation. a highly pleiotropic molecule that modulates several intracellular The activities curcumin have attributed its novel structure. Based on β-diketone moiety, exists keto-enol tautomers, this tautomerism favors interaction binding with wide range enzymes. Several studies shown modulation enzymes including, LOX, COX-2, XO, proteasomes, Ca(2+)-ATPase sarcoplasmic reticulum, MMPs, HAT, HDAC, DNMT1, DNA polymerase λ, ribonucleases, GloI, protein kinases (PKA, PKB, PKC, v-Src, GSK-3β, ErbB2), reductases (TrxR1, AR), GSH, ICDHs, peroxidases (Prx1, Prx2, Prx6) treatment curcumin. Various biophysical analyses reported, which shows underlying terms affinities. current chapter describes how binds Published clinical trial cancer management will also be discussed.

参考文章(124)
Neil G Anderson, ErbB receptor tyrosine kinase inhibitors as therapeutic agents Frontiers in Bioscience. ,vol. 7, pp. d1926- 1940 ,(2002) , 10.2741/A889
Pan Mh, Cheng Al, Jee Sh, Lin Br, Ho Yf, Chen Ca, Pu Ys, Chen Gs, Ko Jy, Hsu Mm, Ming-Shiang W, Shen Ts, Wang Yj, Chen Tm, Tsai Cc, Hsu Ch, Lin Jk, Yu Hs, Lin Jt, Lai Mk, Hsieh Cy, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research. ,vol. 21, pp. 2895- 2900 ,(2001)
Katz Ae, Capodice Jl, Eric G, Gorroochurn P, Cammack As, Stone Ba, Benson Mc, McKiernan Jm, Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trial. Journal of The Society for Integrative Oncology. ,vol. 7, pp. 43- 51 ,(2009)
A Mollbrink, R Jawad, A Vlamis-Gardikas, P Edenvik, B Isaksson, O Danielsson, P Stål, AP Fernandes, None, Expression of thioredoxins and glutaredoxins in human hepatocellular carcinoma: correlation to cell proliferation, tumor size and metabolic syndrome. International Journal of Immunopathology and Pharmacology. ,vol. 27, pp. 169- 183 ,(2014) , 10.1177/039463201402700204
Jonathan G. Bilmen, Shahla Zafar Khan, Masood-ul-Hassan Javed, Francesco Michelangeli, Inhibition of the SERCA Ca2+ pumps by curcumin European Journal of Biochemistry. ,vol. 268, pp. 6318- 6327 ,(2001) , 10.1046/J.0014-2956.2001.02589.X
Wolfgang Henke, Katherine Ferrell, Dawadschargal Bech-Otschir, Michael Seeger, Rüdiger Schade, Peter Jungblut, Michael Naumann, Wolfgang Dubiel, Comparison of human COP9 signalosome and 26S proteasome 'lid' Molecular Biology Reports. ,vol. 26, pp. 29- 34 ,(1999) , 10.1023/A:1006991419464
Christopher D Lao, Mack T Ruffin, Daniel Normolle, Dennis D Heath, Sandra I Murray, Joanne M Bailey, Martha E Boggs, James Crowell, Cheryl L Rock, Dean E Brenner, Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine. ,vol. 6, pp. 10- 10 ,(2006) , 10.1186/1472-6882-6-10
Barbara Simi, Jane R Connor, Cooma Indranie, Chinthalapally V Rao, Bandaru S Reddy, Pamela T Manning, Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Research. ,vol. 62, pp. 165- 170 ,(2002)
Gamze Bora-Tatar, Didem Dayangaç-Erden, Ayhan S. Demir, Sevim Dalkara, Kemal Yelekçi, Hayat Erdem-Yurter, Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies. Bioorganic & Medicinal Chemistry. ,vol. 17, pp. 5219- 5228 ,(2009) , 10.1016/J.BMC.2009.05.042
Yi-Rong Chen, Tse-Hua Tan, Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin Oncogene. ,vol. 17, pp. 173- 178 ,(1998) , 10.1038/SJ.ONC.1201941